Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 8, 2017

View Archived Issues

FDA clears IND for phase II study of 177Lu-PSMA-617

Lupin identifies new PARP-1 inhibitors

Ono Pharmaceutical recaps milestones of third quarter of fiscal 2016

Clinical improvement in ADHD seen with fasoracetam in phase I trial, phase II/III study underway

AstraZeneca reviews milestones of fourth quarter 2016

Phase II trial results of RG-7667 for CMV infection prevention in kidney transplant recipients

HIF1-alpha identified as a target for relapsing triple-negative breast cancer

Longevity Biotech and UNMC awarded continuing grant for the development of LBT-3627

GW Pharmaceuticals reports topline results from phase II study of THC:CBD in glioblastoma

Nanjing Hairong, Nanjing Heron patent loxoprofen derivatives

FDA approves Parsabiv to treat secondary hyperparathyroidism in patients on hemodialysis

Amgen reflects on achievements of fourth quarter 2016

Sunshine Lake Pharma discloses 5-HT reuptake inhibitors/5-HT1A receptor agonists

Targeting zinc finger protein SNAI1 induces apoptosis in bladder cancer cells

Vyome Biosciences announces promising results for VB-1953

Marina Biotech signs licensing agreement for SMARTICLES platform

Flexion Therapeutics' Zilretta NDA accepted for review by FDA

FDA awards fast track designation to Angionetics' Generx

Investigator-sponsored phase I trial of Actinium Pharmaceuticals' Actimab-M begins

Buparlisib shows promise in patients with platinum-pretreated recurrent head and neck carcinoma

Acticor Biotech raises funds to advance lead candidate

GeNeuro, NINDS enter agreement regarding antibodies for ALS

Series B financing at Prexton Therapeutics to support phase II trials of foliglurax

Cancer Research Technology, Tusk Therapeutics and UCL collaborate on cancer immunotherapies

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...